Tech Company Financing Transactions
ReadCoor Funding Round
Decheng Capital, private investors and Pavilion Capital Partners joined a $27 million Series B funding round for ReadCoor. This VC investment round was announced on 1/13/2020.
Transaction Overview
Company Name
Announced On
1/13/2020
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds from the Series B financing will be used to accelerate commercialization of ReadCoor's platform, powered by its proprietary FISSEQ (fluorescent in situ sequencing) technology, which simultaneously reads the sequences of thousands of molecules and visualizes high resolution 3D spatial information within whole cells and tissues.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr. 5th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
At ReadCoor, we envision swifter scientific discoveries, disease diagnosis and drug development from sequencing reads enhanced by panomic spatial data.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Terry
Chief Financial Officer
Benjamin Linden
Vice President
Evan Daugharthy
Vice President
Sam Inverso
VP - Bus. Development
Mel Hernandez
VP - Human Resources
Lori Johnson
VP - Marketing
Jermaine Reid
Browse more venture capital transactions:
Prev: 1/13/2020: MyWorkChoice venture capital transaction
Next: 1/13/2020: SPOTIO venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs